Source disclosure: January 26, 2026
Healthcare & Medical Investment Corporation [3455.T]
TOKYO — Healthcare & Medical Investment Corporation (Code No. 3455) announced today that it has secured financing through a new loan arrangement to refinance existing borrowings due on January 31, 2026. The company will acquire a Social Loan under the JCR Social Finance Framework, as rated by Japan Credit Rating Agency Ltd., which is the highest evaluation level "Social 1(F)".
The corporation, headquartered in Chiyoda Ward, Tokyo, made this decision to replace its current debt obligations totaling 64 billion yen. This loan will be executed via a syndicated loan led by Sumitomo Mitsui Banking Corporation, with additional participation from Sumitomo Mitsui Trust Bank, SBI Sumishin Netto Bank, Shinano Mainichi Bank, Yokohama Bank, and Resona Bank. The loan carries an interest rate of the three-month Tokyo Inter-Bank Offered Rate (TIBOR) plus 0.45 percent.
The funds raised will specifically be used to repay the outstanding debts listed below: - A syndicated loan from Sumitomo Mitsui Banking Corporation amounting to 32 billion yen with an interest rate based on the three-month TIBOR plus 0.45 percent, disbursed on January 29, 2021, maturing on January 31, 2026; - Another syndicated loan from the same bank worth 7 billion yen with an interest rate based on the three-month TIBOR plus 0.35 percent, disbursed on March 30, 2022, also maturing on January 31, 2026; and - Yet another syndicated loan from Sumitomo Mitsui Banking Corporation for 25 billion yen at an annual fixed rate of 0.7225%, disbursed on January 31, 2023, maturing on January 31, 2026.
According to the company's statement, the repayment date for the new Social Loan is set for January 30, 2026. Following the execution of this loan, the total borrowing balance remains unchanged at 46.57 billion yen, comprising short-term loans of 1.97 billion yen and long-term loans of 42.6 billion yen.
This refinancing operation adheres strictly to the guidelines outlined in the SDGs Social Finance Framework, ensuring alignment with sustainable development goals. The JCR Social Finance Framework Evaluation process assesses both the social nature of the funding allocation and the management practices of the entity, providing transparency and accountability in the utilization of such funds.
Healthcare & Medical Investment Corporation emphasizes that there have been no changes since October 30, 2025, regarding risks associated with repayment of these loans, as detailed in their securities report filed during that period. Investors can access further information on the company’s website at https://hcm3455.co.jp/.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing